Galmed Pharmaceuticals (GLMD)

• Market cap: $3.62M
• 1 day: -0.81%
• 5 days: -7.39%
• 1 month: -30.47%
• 3 months: -35.23%
• 6 months: -60.99%
• Year to date: -33.16%
• 1 year: -80%
• 5 years: -99.92%
• 10 years: -99.93%
• Sector: Healthcare
• Industry: Biotechnology

About: Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

Employees: 6